5 Results for "

CDK2-IN-9

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "CDK2-IN-9" in MCE Product Catalog:

Cat. No.: HY-144811
CAS No.: 2919216-33-2
Target:  

CDK Apoptosis

Research Areas:  

Cancer

CDK2-IN-9 is a potent CDK2 inhibitor with an IC50 of 0.63 µM. CDK2-IN-9 shows antiproliferative activity. CDK2-IN-9 induces apoptosis and cell cycle arrest at S and G2/M phase. CDK2-IN-9 has the potential for the research of melanoma .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-101212
CAS No.: 1070790-89-4
Purity:  99.50%
Synonyms: CYC065
Target:  

CDK

Research Areas:  

Cancer

Fadraciclib (CYC065) is a second-generation, orally available ATP-competitive inhibitor of CDK2/CDK9 kinases with IC50s of 5 and 26 nM, respectively .
loading...
    loading...
Cat. No.: HY-181620
Target:  

Molecular Glues CDK

Research Areas:  

Cancer

CDK2 degrader 9 (compound 1) is a CDK2-targeting Molecular Glue with selectivity for GSPT1 and CDK1. CDK2 degrader 9 promotes the ubiquitination and degradation of CDK2 via the ubiquitin ligase pathway. CDK2 degrader 9 is applicable to research related to cancer, solid tumors and hematologic malignancies .
loading...
    loading...
Cat. No.: HY-101212R
CAS No.: 1070790-89-4
Synonyms: CYC065 (Standard)
Target:  

CDK Reference Standards

Research Areas:  

Cancer

Fadraciclib (Standard) is the analytical standard of Fadraciclib (HY-101212). This product is intended for research and analytical applications. Fadraciclib (CYC065) is a second-generation, orally available ATP-competitive inhibitor of CDK2/CDK9 kinases with IC50s of 5 and 26 nM, respectively .
loading...
    loading...
Cat. No.: HY-101212A
Target:  

CDK Drug Isomer

Research Areas:  

Others

(2S,3R)-Fadraciclib is the 2S,3R isomer of Fadraciclib (HY-101212). Fadraciclib is an orally potent ATP-competitive CDK2/CDK9 kinase inhibitor with IC50 values of 5 and 26 nM, respectively .
loading...
    loading...